Cancer Diagnosis
Cryo-RECAF released for staining of cancer cells in frozen tissue sections
Published in Cancer Weekly, June 4th, 2002
BioCurex, Inc., (BOCX) is pleased to announce the commercial launch of its second product, based on the novel and proprietary RECAF marker to the market. Cryo-RECAF is a kit designed for single patient use by pathologists as an aid in diagnosis of cancer during surgical intervention. The test procedure, carried out on frozen sections of tissue material, takes just a few minutes, allowing pathologists to use the test to determine surgical procedures to be followed by the physician while the patient is still under anesthesia.
The Cryo-RECAF assay provides a rapid method for staining cancer cells in similar fashion to the way to its sister product Histo-RECAF performs on...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2002-06-04)
More Articles from Cancer Weekly
- Cancer Therapy
Liposomal accumulation expands utility of doxorubicin in brain tumors - Liver Cancer
Embolization procedure extends survival in hepatocellular carcinoma - Ewing Sarcoma
Adenovirus-mediated therapy sensitizes tumor cells to etoposide - Gynecology
Low-grade cervical lesions likely to regress spontaneously in adolescent women - Head and Neck Cancer
Tumor volume can predict effectiveness of chemoradiation treatment - Small Cell Lung Cancer
Serum growth factor a marker for progression in lung cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
